EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS
TH INTERNATIONAL PROSTATE CANCER AND UROLOGIC ONCOLOGY SYMPOSIUM
NOVEMBER 7-9, 2019 NEW YORK, NY
MOUNTSINAIUROLOGYCME.ORG
HIGHLIGHTS • Over 100 world-renowned faculty • Engaging point-counterpoint debates and • Live 3-D surgical demonstrations, including panel discussion prostate, kidney, bladder procedures • Global exposure with international web streaming of select sessions and events Welcome to the Fourth International Prostate Cancer and Urologic Oncology Symposium.
EDUCATIONAL HIGHLIGHTS • Live 3-D surgery transmission covering complex urologic surgery • Comprehensive didactic lectures from the world’s leading experts in urologic oncology • Robust review of the latest advances in surgical techniques and management of prostate, kidney, and bladder cancer • Personal interaction with world-class faculty • Stimulating point-counterpoint debates on timely topics
DAILY HIGHLIGHTS
PROSTATE DAY 1 THUR. 11/7/19 PROSTATE DAY 2 FRI. 11/8/19 KIDNEY & BLADDER SAT. 11/9/19 • Advanced imaging in genomics • Innovations in the management of • New progress in pre-operative and for prostate cancer castrate-sensitive prostate cancer intra-operative imaging, 3-D • Biomarkers and immunotherapy modelling, and ultra sound • Focus on radiomics and guidance for renal tumors radiogenomics • Update on clinical trials for castrate-resistant treatments for • Novel therapeutics in the • Utility of imaging and artificial prostate cancer management of metastatic renal intelligence in prostate cancer cell carcinomas: VEFG, TKIs, and treatment • Advances in multi-modal immunotherapy treatments for locally advanced • Targeted biopsy and focal therapy prostate cancer • Genomics and biomarkers for options for prostate cancer kidney and bladder cancer • 3-D robotic technique for nerve • Urinary incontinence and sexual sparing • Advances in second line function post-operative treatment transitional cell carcinoma for • Status of bio tech and clinical trials bladder and kidney • Improvements in imaging and in prostate cancer treatment targeted therapy for metastatic • Improvement in surgical technique cancer • Highlights from ASCO and AUA on to maximize outcome for kidney metastatic prostate cancer and bladder cancer • New techniques to improve out- comes for robotic prostatectomy
• Discussion of single port robotic surgery • Clinical trials in nerve sparing and nerve regeneration after prostate cancer surgeries
A full agenda will be available on our symposium website shortly. A full agendPlease a will feel be free available to reference shortly. the Please 2018 agenda feel free on to pages reference 10-20, last year’s which willagenda be similar on pages to the 10-20.2019 program.
2 | MOUNTSINAIUROLOGYCME.ORG NOVEMBER 7 – 9, 2019 NEW YORK, NY EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS
DIRECTOR: ASH TEWARI, MBBS, MCH, FRCS (Hon.) Professor and Chairman of the Department INVITATION of Urology Department of Urology TO EXHIBIT/SPONSOR [email protected] CO-DIRECTOR: Dear Industry Colleagues: KETAN BADANI, MD Professor of Urology and Vice Chairman of the Department of Urology On behalf of the Department of Urology at the Icahn School of Medicine at Mount Department of Urology Sinai in New York City, I am thrilled to invite you to participate in the Fourth [email protected] International Prostate Cancer and Urologic Oncology Symposium set for
November 7-9, 2019 in New York! This year’s program is our most innovative yet, PLANNING COMMITTEE: complete with over 100 world-renowned experts who will provide in-depth training NINA BHARDWAJ, MD, PhD on cutting-edge medical advances and ground-breaking treatment approaches for Professor of Medicine, Hematology, prostate, kidney, bladder, and renal cell cancers. There will also be a unique focus this and Medical Oncology Department of Medicine, Hematology, and year on critical issues in immuno-oncology and sexual health, as well as multiple live Medical Oncology surgeries and focused demonstrations. Ranked among the nation’s best for Urology [email protected] in the “Best Hospitals” issue of U.S. News & World Report, the physicians of Mount Sinai Urology are leaders in robotic surgery and minimally invasive procedures to CARLOS CORDON-CARDO, MD, PhD Professor and Chairman treat prostate, kidney, and bladder cancers. Join the Mount Sinai Department of of the Department of Pathology Urology for an interactive symposium with 3-D demonstrations of the latest robotic Department of Pathology surgery techniques for prostate, kidney and bladder cancer. Directed by the world’s [email protected] leading robotic experts and taught by an internationally renowned faculty, attendees MATTHEW GALSKY, MD gain emerging and practical tools to optimize their robotic surgery skills. We are Professor of Medicine, Hematology, and Medical Oncology also on the forefront of diagnosis and treatment for urinary tract conditions, kidney Department of Medicine, Hematology, and stones, infertility, erectile dysfunction, female pelvic medicine, and pediatric urologic Medical Oncology conditions. [email protected] As you will see in the enclosed Partnership Prospectus, we are offering several MANTU GUPTA, MD, FRCS (Glasg) Professor of Urology sponsorship and exhibitor opportunities for this year’s program, to help you gain Department of Urology access to, and inform, symposium attendees about your company, your research [email protected] development program and your marketed products. We expect over 500 attendees ADAM MARGOLIN, PhD at this year’s program, including physicians, nurses, pharmacists, and researchers, all Professor and Chairman of whom will be actively engaged in discussions across the prostate and urological of the Department of Genetics and Genomic Science cancer landscape. Department of Genetics and Genomic Science Affiliating with the Fourth International Prostate Cancer and Urologic Oncology [email protected] Symposium is the most direct route in meeting and sharing your products with some WILLIAM OH, MD of the most well-known, respected health care providers and decision makers in the Professor of Medicine, Hematology, urologic community. As an essential part of the symposium, you will be able to make and Medical Oncology invaluable connections with key opinion leaders, academic researchers and other Department of Medicine, Hematology, and Medical Oncology industry stakeholders as we continue the tradition of advancing the level of science [email protected] and quality of care in prostate and urologic oncology. MICHAEL PALESE, MD To this end, I invite you to review the attached Partnership Prospectus to learn Professor of Urology more about the program and to find out how to reserve your prime exhibit space Department of Urology today. More information can be found at mountsinaiurologycme.org. If you have [email protected] any questions, please contact Ms. Jennifer Berens at 425-442-13140 or via email at ERIC SCHADT, PhD Dean of Precision Medicine, Professor of [email protected]. We look forward to having you as our industry partner Genetics and Genomic Science for this year’s program! Department of Genetics and Genomic Science Sincerely, [email protected]
BACHIR TAOULI, MD Professor of Radiology Department of Radiology [email protected]
Ash Tewari, MBBS, MCh, FRCS (Hon.) Professor, Icahn School of Medicine at Mount Sinai Kyung Hyun Kim, MD, Chair of the Department of Urology Chair, Milton and Carroll Petrie Department of Urology, Mount Sinai Health System
MOUNTSINAIUROLOGYCME.ORG | 3 • 2017 •• 2018 ••• FACULTY
Ronney Abaza MD, FACS Ohio Health Dublin Alexander Haese MD Martini-Clinic Prostate Vipul Patel MD, FACS Florida Hospital Cancer Methodist Hospital Cancer Center, Hamburg, Germany Institute Urologic Oncology Program Mutahar Ahmed MD Hackensack University Misop Han MD Johns Hopkins School of Peter Pinto MD National Cancer Institute Medical Center, New Jersey Center for Medicine Urologic Oncology Branch Prostate Cancer & Urology Stefanie Hectors PhD Mount Sinai - Icahn Francesco Porpiglia MD San Luigi Gonzaga Olof Akre MD Mount Sinai - Department School of Medicine Hospital, University of Turin of Urology/Karolinska Institutet Ashok Hemal MD Wake Forest Baptist Health - James Porter MD Swedish Urology Group Walter Artibani MD University Hospital Institute for Regenerative Medicine Isaac Powell MD Wayne State University Verona, Italy Michael Herman MD South Nassau Surgical Sciences Ketan Badani MD Mount Sinai - Department Communities Hospital Rajveer Purohit MD Mount Sinai -Department of Urology Markus Hohenfellner MD University Hospital of Urology Mitchell C. Benson MD Columbia University Heidelberg Department of Urology Ganesh Raj MD, PhD UT Southwestern Medical Medical Center Jim Hu MD, MPH Weill Cornell Medicine Center Department of Urology Thomas Bessede MD CHU Bicetre, Bicetre Simon Hughes PhD King’s College London Abhay Rane OBE, MS, FRCS, FRCS (Urol) East Surrey Pari-South University John Isaacs PhD Johns Hopkins School of Hospital, United Kingdom Jerry Blaivas MD Mount Sinai - Department Medicine Art Rastinehad DO Mount Sinai - Department of Urology Jihad Kaouk MD Cleveland Clinic - Department of Urology Maurizio Buscarini MD Universita Campus of Urology Amanda Rhee MD Mount Sinai - Department Bio-Medico di Roma Steven Kaplan MD Mount Sinai - Department of Anesthesiology, Perioperative & Pain Umberto Capitanio MD San Raffaele Hospital of Urology Medicine Milan, Italy Deepak Kapoor MD Mount Sinai - Department Mack Roach, III MD, FACR University of Giuseppe Carrieri MD Department of Urology of Urology California San Francisco University of Foggia Aaron Katz MD , FACS NYU Winthrop Hospital - Kenneth Rosenzweig MD Mount Sinai - Brian Chapin MD University of Texas - Department of Urology Department of Radiation Oncology Department of Urology, Division of Surgery Isaac Kim MD, PhD Rutgers - Cancer Institute of Jaspreet Sandhu MD Memorial Sloan Kettering Philippa Cheetham MD, FRCS (Urol) Mount Sinai - New Jersey Douglas Scherr MD Weill Cornell Medicine Department of Medicine Joseph Kim MD Yale School of Medicine Ryoichi Shiroki MD Fujita Health University Mallikarjuna Chiruvella MD, PhD Asian institute School of Medicine of Nephrology and Urology Hyderabad, Alexander Kirschenbaum MD Mount Sinai - Telangana, India Department of Urology Brian Shuch MD UCLA Medical Center, Barbara Chubak MD Mount Sinai - Department Natasha Kyprianou PhD Mount Sinai - John Sfakianos MD Mount Sinai - Department of Urology Department of Urology of Urology Ralph Clayman MD UC Irvine Jaime Landman MD UC Irvine Health Alan Sim MD Mount Sinai - Department Vincent Laudone MD of Anesthesiology, Perioperative & Pain Jonathan Coleman MD Medicine Memorial Sloan Kettering Memorial Sloan Kettering Susan Slovin MD, PhD Memorial Sloan Kettering David Lee MD, FACS Penn Presbyterian2019 Medical Justin Collins MBChB, MD, FRCS Karolinska Institute Center - Division of Urology Joseph Smith MD Vanderbilt University Medical Center Carlos Cordon-Cardo MD, PhD Mount Sinai - Herbert Lepor MD NYU Langone Health Department of Pathology Bobby Liaw MD Mount Sinai - Department of Prasanna Sooriakumaran MD, PhD, FRCSUrol, FEBU University College London Hospital Fabrizio Dal Moro MD, FEBU University of Medicine, Hematology and Medical Oncology Padova - Department of Surgery, Oncology, Daniel Lin MD University of Washington - Rene Sotelo MD Keck School of Medicine at and Gastroenterology Department of Urology USC Michael Droller MD Mount Sinai - Department Mark Litwin MD Ronald Reagan UCLA Medical Gunnar Steineck MD, PhD University of of Urology Center Department of Urology Gothenburg Ithaar Derweesh MD UC San Diego School of Massimo Loda MD Weill Cornell Medicine Cora Sternberg MD Weill Cornell Medicine Medicine Ravi Madan MD National Cancer Institute Michael Stifelman MD Hackensack University Mihir Desai MD Keck Hospital of USC Medical Center Reza Mehrazin MD Mount Sinai - Department Majid Eshghi MD, FACS Urology Center of of Urology Gustavo Stolovitzky PhD IBM’s Thomas J. Westchester, New York Watson Research Center Mani Menon MD Henry Ford Health System Daniel Eun MD Temple University - Lewis Katz Ash Tewari MBBS, MCh Mount Sinai - Department Nihal Mohamed PhD Mount Sinai - Department School of Medicine of Urology of Urology Bishoy Faltas MD Weill Cornell Medicine Quoc-Dien Trinh MD Brigham and Women’s Aron Monish MD, MCh Keck School of Medicine Hospital Gerardo Fernandez MD Mount Sinai - at USC Department of Urology Department of Pathology Che-Kai Tsao MD Mount Sinai - Department of William Oh MD Mount Sinai - Department of Medicine, Hematology and Medical Oncology Daniel Gainsburg MD Mount Sinai - Medicine,Hematology and Medical Oncology Department of Anesthesiology, Perioperative Robert Valenzuela MD Mount Sinai - Yen-Chuan Ou MD Taichung Veterans General and Pain Medicine Department of Urology Hospital, Taichung, Taiwan Reza Ghavamian MD Northwell Health Dolan Arnauld Villers MD, PhD University of Lille - Sait Ozturk PhD Mount Sinai - Department of Family Health Center Urology Department Oncological Sciences Amit Ghose MS, FRCS Apollo Gleaneagles Wei-Chun (Jim) Weng MD Division of Ganesh Palapattu MD University of Michigan Hospital, Kolkata, India Urology, Department of Surgery, Tung’s Medical School Taichung MetroHarbor Hospital Alvin Goh MD Memorial Sloan Kettering Michael Palese MD Mount Sinai - Department Cancer Center Peter Wiklund MD, PhD Mount Sinai - of Urology Department of Urology Nate Gross MD Doximity Vito Pansadoro MD Vincenzo Pansadoro Jorn Witt MD St. Antonius Hospital Gronau, Jonathan Haas MD NYU Winthrop Hospital Foundation, Centre of Robotic Laparoscopy Germany in Rome, Italy Ofer Yossepowitch MD Tel Aviv Sourasky Dipen Parekh MD University of Miami Health Medical Center System John Kellogg Parsons MD UC San Diego Health
MOUNTSINAIUROLOGYCME.ORG | 5 FOURTH INTERNATIONAL PROSTATE CANCER AND UROLOGIC ONCOLOGY SYMPOSIUM • NOVEMBER 7-9, 2019 NEW YORK, NY
The Fourth International Prostate Cancer and Urologic
Oncology Symposium offers industry sponsors an exclusive
opportunity to interact with and educate clinicians on the latest
medical techniques and products. By partnering with the Icahn
School of Medicine at Mount Sinai Hospital, your company can
have unprecedented access to, and visibility from, attendees and
faculty through a wide range of custom sponsorship packages,
including strategic placement of corporate logos, and engaging
exhibitor booths.*
*Corporate functions may not be held concurrent with official symposium/congress’ scientific or social functions. Any function, regardless of size and location, must be approved by the course’s industry relations department.
6 | MOUNTSINAIUROLOGYCME.ORG NOVEMBER 7 – 9, 2019 NEW YORK, NY EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS
OPPORTUNITIES FOR SPONSORSHIP
SPONSORSHIP PACKAGES
PLATINUM LEVEL: $20,000 GOLD LEVEL: $15,000 This is the most elite level of sponsorship and the most visible way to support This sponsorship level clearly positions your company as a leader in the field. the Fourth International Prostate Cancer and Urologic Oncology Symposium. Key benefits include all Silver Level offerings, a larger 10’ Exhibit Space, along Among other benefits, this level of sponsorship includes a larger 7' x 20' exhibit with recognition as a sponsor of one of the attendee refreshment breaks space, sponsorship of one Charging Station with company logo displayed and Includes: placed between the registration area and the entrance of the Exhibit Hall and a • 7' x 10' Draped Exhibit Booth, 1- 6' Draped Table, 2 Chairs, 1 10-Amp Outlet prime exhibit location. • Recognition as a sponsor of one of the morning or afternoon breaks Includes: (Company logo placed prominently on signage acknowledging sponsorship) • 7’ x 20’ Draped Exhibit Booth, 1- 6’ Draped Table, 2 Chairs, 1 10-Amp Outlet • Company logo placed on recognition banner immediately outside of • Company Logo placed on Charging Station, along with signage with company exhibit hall logo acknowledging sponsorship. • Recognition in attendee course materials & supporter slides during breaks • Company logo placed on recognition banner immediately outside of exhibit hall • 6 Full-Meeting Access Badges • Recognition in attendee course materials & supporter slides during breaks • 10 Full-Meeting Access Badges
SILVER LEVEL: $10,000 BRONZE LEVEL: $5,000 This sponsorship level offers you access to and visibility from program This sponsorship level includes the ability to showcase your company and attendees through various sponsorship offerings. Key benefits include 6' table products with three-day visibility as an Exhibitor with a standard top booth, placement of company logo throughout symposia signage and a 6' table top booth choice exhibit location. • 8' Draped Exhibit Space, 1- 6' Draped Table, 2 Chairs, 1 10-Amp Outlet • 8' Draped Exhibit Space, 1- 6' Draped Table, 2 Chairs, 1 10-Amp Outlet • Recognition in attendee course materials & supporter slides during breaks • Company logo placed on recognition banner immediately outside of • 2 Full-Meeting Access Badge exhibit hall • Recognition in attendee course materials & supporter slides during breaks • 4 Full-Meeting Access Badges
MOUNTSINAIUROLOGYCME.ORG | 7 FOURTH INTERNATIONAL PROSTATE CANCER AND UROLOGIC ONCOLOGY SYMPOSIUM • NOVEMBER 7 – 9, 2019 NEW YORK, NY
OPPORTUNITIES FOR SPONSORSHIP
ADDITIONAL SPONSORSHIP OPPORTUNITIES CUSTOM PROGRAM LANYARDS (Exclusive): ATTENDEE WIFI (Exclusive): $7,500 $10,000 Showcase company name on the lanyards given to each participant for their Keep attendees connected with free Wi-Fi access throughout the conference meeting badges. space with your company name as the network name and brand and logo prominently displayed with each login. CUSTOMIZED HOTEL ROOM KEY CARDS/ WiFi cards with company logo acknowledging sponsorship is given out to each SLEEVES FOR FACULTY ROOMS (Exclusive): $7,500 registered attendee upon badge pick-up.
Unlock doors to all the symposium faculty rooms by having your insignia, brand, CHARGING STATION (2 Available): or products displayed on the hotel room key cards & sleeves. $15,000 Showcase your company logo on a charging station with prime location in the ATTENDEE MEETING APP (Exclusive): $10,000 center of the Exhibit Area or directly outside the Registration Area. Recognition as App sponsor on Banner of Attendee Apps.
SPONSORSHIP INFORMATION
MEETING DETAILS PAYMENT, CANCELLATIONS AND REFUNDS • The Fourth International Prostate Cancer and Urologic Oncology Symposium • Payment should be made as soon as possible to secure the exhibit space (on a • Thursday, November 7 – Saturday, November 9, 2019 first come, first served basis). It is due no later than October 17, 2019.
• The Mount Sinai Hospital CONTACT INFORMATION Stern Auditorium For more information about supporting the Fourth International Prostate Cancer 1 Gustave L. Levy Place and Urologic Oncology Symposium, please contact: New York, NY 10029-6574 • Over 100 world-renowned faculty Sponsorship Opportunities/Educational Grants: Gaffney Events, LLC • Over 500 attendees Ms. Jennifer Berens EXHIBIT SCHEDULE 425-442-1314 • Times are subject to change without notice. [email protected] • Exhibit Set-Up: Wednesday, November 6, 2:00 pm – 6:00 pm On-Site Meeting Support & Exhibit Coordination: • Exhibit Hours Gaffney Events, LLC Thursday, November 7, 7:00 am – 6:00 pm Ms. Tricia Gaffney Friday, November 8, 7:00 am – 6:00 pm 206.310.3612 Saturday, November 9, 7:00 am – 6:00 pm [email protected] Exhibit Teardown: Saturday, November 9, 3:30 pm or after the afternoon break
8 | MOUNTSINAIUROLOGYCME.ORG NOVEMBER 7 – 9, 2019 NEW YORK, NY EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS
SPONSORSHIP FORM
FOURTH ANNUAL INTERNATIONAL PROSTATE CANCER AND UROLOGIC ONCOLOGY SYMPOSIUM Mount Sinai Hospital November 7–9, 2019 mountsinaiurologycme.org Company Name (As it should appear on printed material)
Contact Person (individual to whom all exhibitor information will be forwarded) Title
Street Address
City State Zip
Telephone Fax Email
Product
BADGES (please look at partnership opportunity descriptions to determine your badge allotment)
Representative Name (First, Last) Title Email Address Phone
PARTNERSHIP LEVELS
PLATINUM LEVEL: $20,000 SILVER LEVEL: $10,000 Customized Hotel Room Key Cards $5,000 (EXCLUSIVE) Charging Station $15,000 (2 Available) GOLD LEVEL: $15,000 BRONZE LEVEL: $5,000 Attendee Meeting App $7,500 (EXCLUSIVE) Attendee WiFi $10,000 (EXCLUSIVE) Custom Program Lanyards $7,500 (EXCLUSIVE)
PAYMENT
Make checks payable to: Gaffney Events Educational Trust EIN #: 47-3109028 Mail: Gaffney Events, 27322 NE 143rd Place, Duvall, WA 98019 Fax: (425)788-0668 Email: [email protected] Phone: (425) 442-1314
*For all sponsorship-related questions, please contact Ms. Jennifer Berens at 425-442-1314 or via email at [email protected] | 9
MOUNTSINAIUROLOGYCME.ORG | 9 A full agenda will be available shortly. Below please find last year’s agenda. THURSDAY, DECEMBER 13, 2018 MORNING AGENDA
7:00 am – 7:10 am Welcome and Introduction Stern Auditorium Ash Tewari, MBBS, MCh
Audience Response Question with App Orientation 7:10 am – 7:15 am Ketan K. Badani, MD
The Hans E. Shapira Lecture 7:15 am – 7:45 am Peter Scardino, MD, FACS Prostate Cancer: A Perspective; the Right Treatment for the Right Patient at the Right Time Epidemiology, Screening And Diagnosis Of PANELISTS Prostate Cancer Guiseppe Carrieri, MD Philippa Cheetham, MD John Kellogg Parsons, MD Samir Taneja, MD
7:45 am – 7:55 am Epidemiology of Prostate Cancer Olof Akre, MD, PhD
7:55 am – 8:10 am How Has the Task Force Hurt Cancer Screening? Jim Hu, MD, MPH
SURGEON 8:10 am – 9:40 am 3-D Live Surgery: Robot Assisted Radical Prostatectomy Ash Tewari, MBBS, MCh
MODERATORS Ketan K. Badani, MD, & Alberto Martini, MD
PANELISTS Fabrizio Dal Moro, MD,FEBU Ashok Hemal, MD, MCh Peter Scardino, MD, FACS
9:40 am – 9:50 am Q&A for Live Surgery
9:50 am- 10:05am Coffee Break (Courtesy of IntegraConnect)
10:05-10:15am Genomic Landscape of Prostate Cancer Christopher Barbieri, MD, PhD
Genomics, Radiomics and Racial Disparities in 10:15 am-11:00 am Ash Tewari, MBBS, MCh Prostate Cancer
Defining and Modelling Molecular Subtypes of 11:00 am – 11:10 am Christopher Barbieri, MD, PhD Prostate Cancer
11:10 am – 11:20 am Biomarkers in Prostate Cancer Christopher Evans, MD
Emperor of All Maladies: Cancer and the Implications for Siddhartha Mukherjee, MD, DPhil 11:20 am – 12:20 pm Prostate Cancer —Featured Guest Speaker
10 | MOUNTSINAIUROLOGYCME.ORG 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS THURSDAY, DECEMBER 13, 2018 THURSDAY, DECEMBER 13 MORNING AGENDA AFTERNOON AGENDA
12:25 pm – 1:25 pm Lunch
PANELISTS Imaging And Biopsy In Prostate Cancer Chris Barberie, MD, Christopher Evans, MD; Jim Hu, MD, MPH Kenneth Rosenzweig, MD Ash Tewari, MBBS, MCh
1:25 pm – 1:35 pm Imaging in Prostate Cancer Art Rastinehad, DO
1:35 pm – 1:45 pm Role of PSMA Scan in Prostate Cancer Markus Hohenfellner, MD
1:45 pm – 1:55 pm Targeted-Biopsy Techniques Samir Taneja, MD
When to Skip Biopsy: Before Diagnosis, During AS, 1:55 pm – 2:05 pm Arnauld Villers, MD, PhD Follow-Up of FT
Audience Response Question with App
2:05 pm – 2:15 pm Predictive Models for Prostate Cancer Carl Olsson MD
PANELISTS Christopher Barbieri, MD, PhD Immunotherapy And Prostate Cancer Susan Slovin, MD, PhD Ash Tewari, MBBS, MCh
2:15 pm – 2:25 pm Immunotherapy and Prostate Cancer Ravi Madan, MD
2:25 pm – 2:35 pm Immunotherapy for Prostate Cancer in a Neo-adjuvant Sujit Nair, PhD Setting
2:35 pm – 2:40 pm Audience Response Question with App/Coffee Break
PANELISTS Focal Therapy Jonathan Coleman, MD Jim Hu, MD, MPH Aaron Katz, MD
2:40 pm – 2:50 pm Focal Therapy: Is It Ready for Prime Time? Herbert Lepor, MD
Partial Gland Ablation and Focal Therapy for 2:50 pm – 3:00 pm Prostate Cancer Jonathan Coleman, MD
3:00 pm – 3:10 pm The Role of Salvage Cryotherapy and the Outcomes Aaron Katz, MD
3:10 pm – 3:20 pm Complications of Focal Therapy Rene Javier Sotelo, MD
3:20 pm – 3:25 pm Q&A Focal Therapy
MOUNTSINAIUROLOGYCME.ORG | 11 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS THURSDAY, DECEMBER 13 LATE AFTERNOON & EVENING AGENDA
PANELISTS Mitchell Benson, MD Management Of Low And Intermediate Risk Markus Hohenfellner, MD 3:25 pm – 4:10 pm Prostate Cancer Prasanna Sooriakumaran, MD, PhD Atsushi Takenaka, MD, PhD
3:25 pm – 4:10 pm New Anatomy of Prostate for Robotic Prostatectomy Ash Tewari, MBBS, MCh
4:10 pm – 4:20 pm RARP: Surgical Steps for Better Oncological and Jorn Witt, MD Functional Outcomes
4:20 pm – 4:30 pm Global Perspectives in Robotic Surgery: A Healthy Market Maurizio Buscarini, MD, PhD, is a Competitive One MPH-MBA
4:30 pm – 4:40 pm Management of BPH in Active Surveillance Patients Steven Kaplan, MD
4:40 pm – 4:45 pm Q&A Management of Low and Intermediate Risk Prostate Cancer
PANELISTS Management Of Advanced Prostate Cancer Bobby Liaw, MD Daniel W. Lin, MD William Oh, MD Peter Scardino, MD, FACS
4:45 pm - 5:15 pm State of ART Lecture Arie Belldegrun, MD Innovative Drug Development and the Academic Urologic Oncologist: A Personal Experience
5:15 pm – 5:25 pm Management of Advanced Prostate Cancer Howard Schiff, MD
5:25 pm – 5:35 pm Metastatic Hormone-Sensitive Prostate Cancer: What the Michael Cookson, MD Urologist Needs to Know
5:35 pm –5:50 pm Utilization of Intraoperative Radioactive Seed Ketan K. Badani, MD Implantation During Robotic Prostatectomy – A Phase I Trial
5:50 pm – 5:55 pm Q&A: Management of Advanced Prostate Cancer
5:55 pm – 6:00 pm Conclusion Ash Tewari, MBBS, MCh
12 | MOUNTSINAIUROLOGYCME.ORG 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS THURSDAY, DECEMBER 13 AFTERNOON BREAKOUT SESSION: IMMUNOTHERAPY & TUMOR MICROENVIRONMENT, PART I MODERATORS: NINA BHARDWAJ, MD, PHD AND ARIE BELLDEGRUN, MD, FACS
1:30 pm – 1:40 pm Cancer Immunotherapy and Targeting Innate Immune Cells Nina Bhardwaj, MD, PhD
1:40 pm – 1:43 pm Q&A Cancer Immunotherapy and Targeting Innate Immune Cells
1:43 pm – 1:53 pm Prostate Cancer Radiomics Study Stefanie Hectors, PhD
1:53 pm – 1:56 pm Q&A Prostate Cancer Radiomics
1:56 pm – 2:06 pm Targeting DNA Repair Deficiency in Prostate Cancer Joseph Kim, MD
2:06 pm – 2:09 pm Q&A Targeting DNA Repair Deficiency in Prostate Cancer
2:09 pm –2:19 pm PRINT Study Discussion Bobby Liaw, MD
2:19 pm – 2:22 pm Q&A PRINT Study Discussion
Variable Expression of 5-Alpha Reductase 2 in BPH and Advanced 2:22 pm – 2:32 pm Prostate Cancer: Opportunities for Personalized Care Aria Olumi, MD Variable Expression of 5-Alpha Reductase 2 in BPH and Advanced Prostate Cancer: 2:32 pm – 2:35 pm Q&A Opportunities for Personalized Care
2:35 pm – 2:45 pm Combination Immunotherapy Strategies Ravi Madan, MD
2:45 pm – 2:48 pm Q&A Combination Immunotherapy Strategies
2:48 pm – 2:58 pm A Pragmatic Approach to Radiation Strictures Jerry Blaivas, MD
2:58 pm – 3:01 pm Q&A A Pragmatic Approach to Radiation Strictures
3:01 pm – 3:11 pm Urethral Strictures Rajveer Purohit, MD, MPH
3:11 pm – 3:14 pm Q&A Urethral Strictures
3:14 pm – 3:24 pm Same Old Sling? The Evolution of Perineal Sling Surgery Neil Grafstein, MD for Treatment of Post-Prostatectomy Incontinence Q&A Same old Sling? The Evolution of Perineal Sling Surgery for Treatment of Post-Prostatectomy 3:24 pm – 3:27 pm Incontinence
3:27 pm – 3:37 pm Treatment of Male Hypogonadism Using Non-Testosterone Natan Bar-Chama, MD Therapies 3:37 pm – 3:40 pm Q&ATreatment of Male Hypogonadism Using Non-Testosterone Therapies Complications of Robot-Assisted Laparoscopic Surgery 3:40 pm – 3:50 pm Daniel Gainsburg, MD Distant from the Surgical Site 3:50 pm – 3:53 pm Q&A Complications of Robot-Assisted Laparoscopic Surgery Distant from the Surgical Site
3:53 pm – 4:03 pm Quality of Life After Urologic Cancer Nihal Mohammed, PhD
4:03 pm – 4:06 pm Q&A Quality of Life After Urologic Cancer Advances in Artificial Intelligence Applied to Prostate 4:06 pm – 4:16 pm Gerardo Fernandez, MD Cancer 4:16 pm – 4:19 pm Q&A Advances in Artificial Intelligence Applied to Prostate Cancer Treatment of Locally Recurrent Prostate Cancer 4:19 pm – 4:29 pm Johnathan Haas, MD after Whole Gland Cryotherapy using CyberKnife
4:29 pm – 4:31 pm Q&A Treatment of Locally Recurrent Prostate Cancer after Whole Gland Cryotherapy using CyberKnife
4:31 pm – 6:00 pm JOIN THE MAIN SESSION
MOUNTSINAIUROLOGYCME.ORG | 13
4:29 pm – 4:39 pm Q&A Treatment of Locally Recurrent Prostate Cancer after Whole Gland Cryotherapy using CyberKnife 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS FRIDAY, DECEMBER 14 MORNING AGENDA
7:00 am – 7:10 am Day Two Welcome Stern Auditorium Ash Tewari, MBBS, MCh
Radical Prostatectomy PANELISTS Arul Chinnaiyn, MD, PhD Douglas Scherr, MD Prasanna Sooriakumaran, MD PhD, FRCS Urol, FEBU Ofer Yossepowitch, MD
7:10 am – 7:25 am Chasing Complications Following RALP Francesco Montorsi, MD 7:25 am – 7:35 am Role of Surgery in Advanced Disease and Salvage Lymph Vincent Laudone, MD Node Dissections 7:35 am – 7:45 am Positive Margins After RARP Peter Wiklund, MD, PhD
7:50 am – 8:00 am Audience Response Question with App BREAK / VISIT EXHIBITS
SURGEON 8:00am – 9:30 am 3-D Live Surgery: Robot Assisted Radical Prostatectomy Ash Tewari, MBBS, MCh
MODERATORS Ketan K. Badani, MD, & Francesco Montorsi, MD
PANELISTS Michael Cookson, MD Reza Ghavamian, MD Francesco Porpiglia, MD Management of Lymph Node-Positive Prostate Cancer and 9:30 am – 9:40 am Brian Chapin, MD Neoadjuvant Systemic Therapy in Localized Prostate Cancer
Radical Prostatectomy in Oligometastatic Disease: Prasanna Sooriakumaran, MD, 9:40 am – 9:55 am Experience from the UK RCT TRoMbone PhD The Role Local Therapy in Oligo-Metastatic Prostate 9:55 am – 10:10 am Markus Graefen, MD Cancer Cytoreductive Radical Prostatectomy 10:10 am – 10:20 am Isaac Kim, MD, PhD in Men with M1a or M1b Disease
PANELISTS SURS – Panel Discussion Erik Goluboff, MD Nailing Prostate Cancer: Which Techniques, Ashok Hemal, MD, MCh Why, When And How? Michael Herman, MD John Sfakianos, MD
10:20 am – 10:35 am Outpatient Prostatectomy David Lee, MD
10:35 am - 10:50 am Retzius-Sparing Trans-Douglas Radical Prostatectomy Markus Hohenfellner, MD
10:50 am – 11:05 am 3D Image-Guided Surgery in Prostate Cancer: From Francesco Porpiglia, MD Cognitive to Augmented Reality Procedures
11:05 am – 11:20 am Less is More for Prostate Cancer Abhay Rane, OBE Robot-Assisted Radical Prostatectomy 11:20 am – 11:45 pm Ash Tewari, MBBS, MCh Perineal Robotic Prostatectomy 11:45 pm – 12:00 pm Jihad Kaouk, MD Q&A Radical Prostatectomy 12:00 pm – 12:10 pm
14 | MOUNTSINAIUROLOGYCME.ORG 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS FRIDAY, DECEMBER 14 AFTERNOON AGENDA
12:10 pm – 1:15 pm Lunch
1:15 pm – 1:45 pm DEBATE MODERATOR: Creed 2: Peter Wiklund, MD, PhD Battle of the Stars: Radiotherapy vs. Surgery For Locally Advanced and Advanced Prostate Cancer DEBATORS Surgery: Prasanna Sooriakumaran, MD, PhD Radiotherapy: Mack Roach, III, MD
Audience Response Question with App
MAIN AFTERNOON SESSION I: MODERATOR: Advanced Prostate Cancer Markus Hohenfellner, MD David Lee, MD Mani Menon, MD Abhay Rane, OBE
1:45 pm – 2:00 pm Recent Advances in Management of Advanced Prostate Wlliam Oh, MD Cancer Promising Clinical Trials in Prostate Cancer 2:00 pm – 2:15 pm Cora Sternberg, MD
Biomarkers and Immunotherapy 2:15 pm – 2:30 pm Susan F. Slovin, MD, PhD
2:30 pm – 2:40 pm Precision Focal ProstatectomyI Mani Menon, MD
2:40 pm – 2:55 pm The Online Urologist: From Separating Signal Noise in Nate Gross, MD Keeping with Research, to Boosting Referrals, Social, Mobile, and Machine Learning Technologies are Transforming Medicine
2:55 pm – 3:05 pm The QOL Comparison Between Open vs. Robotic Misop Han, MD Prostatectomy Open vs. Robotic Prostatectomy: Lessons Learned from Olof Akre, MD, PhD 3:05 pm – 3:20 pm the Swedish LAPPRO Trial 3:20 pm – 3:30 pm Why is it Important for Urology to Treat Castrate- Mitchell Benson, MD Resistant Prostate Cancer?
3:30 pm – 3:45 pm Radical Prostatectomy vs. Watchful Waiting: 29 Years Gunnar Steineck, MD, PhD Follow Up from the SPCG4 Study
3:45 pm – 3:50 pm Q&A
MOUNTSINAIUROLOGYCME.ORG | 15 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS FRIDAY, DECEMBER 14 AFTERNOON AGENDA
Sexual Health Following Prostatectomy PANELISTS Natan Bar-Chama, MD Barbara Chubak, MD Doron Stember, MD Atsushi Takenaka, MD, PhD Robert Valenzuela, MD 3:50 pm – 4:05 pm Atsushi Takenaka, MD, PhD Orgasmic Dysfunction Following RARP
Stem Cells and Cytokines: Hope or Hype? Reviewing the 4:05 pm - 4:20 pm Evidence for the Use of These for Prophylaxis Against Barbara Chubak, MD and Treatment of Post-Prostatectomy ED
4:20 pm - 4:35 pm Sexual Function After RALP Doron Stember, MD
Emerging Treatment Options for Post-Prostatectomy 4:35 pm - 4:50 pm Robert Valenzuela, MD Climacturia Treatment of Male Hypogonadism Using Non-Testosterone 4:50 pm - 5:05 pm Natan Bar-Chama, MD Therapies MAIN AFTERNOON SESSION II: PANELISTS Innovations In Oncology Mani Menon, MD Gustavo Stolovitzky, PhD Ash Tewari, MBBS, MCh
5:05 pm - 5:20 pm Gene-Oncogene Interactions Carlos Cordon-Cardo, MD, PhD
5:20 pm - 5:35 pm Novel Therapeutic Targeting of Advanced Cancer Natasha Kyprianou, PhD
5:35 pm - 5:50 pm Awards Ceremony
5:50 pm - 6:00 pm Closing Remarks Ash Tewari, MBBS, MCh
16 | MOUNTSINAIUROLOGYCME.ORG 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS FRIDAY, DECEMBER 14 AFTERNOON SESSION: IMMUNOTHERAPY & TUMOR MICROENVIRONMENT, PART II MODERATORS: DANIEL PETRYLAK, MD AND JEFFREY BOCKMAN, PhD
1:15 pm – 1:25 pm Management of Incontinence After Radiation or Surgery Rajveer S. Purohit, MD, MPH
1:25 pm – 1:28 pm Q&A Management of Incontinence After Radiation or Surgery
1:28 pm – 1:38 pm Overview of Immunotherapy for Prostate Cancer Daniel Petrylak, MD
1:38 pm – 1:41 pm Q&A Current Status of Immune Therapy for Prostate Cancer
Oligometastases and New Therapies for Bone Metastatic 1:41 pm – 1:51 pm Alexander Kirschenbaum, MD Prostate Cancer 1:51 pm – 1:54 pm Q&A Oligometastases and New Therapies for Bone Metastatic Prostate Cancer
1:54 pm – 2:04 pm Linking Scientific and Clinical Issues to Commercial/ Jeffrey Bockman, PhD Strategic Considerations
2:04 pm – 2:07 pm Q&A Linking Scientific and Clinical Issues to Commercial/Strategic Considerations
Tumor Suppressor, PTEN’s Role in Prostate Cancer 2:07 pm – 2:17 pm Sait Ozturk, PhD Progression
2:17 pm – 2:20 pm Q&A Tumor Suppressor, PTEN’s Role in Prostate Cancer Progression
Urinary Adverse Events After Prostate Cancer Treatment 2:20 pm – 2:30 pm Jaspreet Sandhu, MD (RP, RT, etc.)
2:30 pm – 2:33 pm Q&A Urinary Adverse Events After Prostate Cancer Treatment
2:33 pm – 2:43 pm Science That Underlies Prostate Cancer Racial Disparity Isaac Powell, MD
2:43 pm – 2:46 pm Q&A Science That Underlies Prostate Cancer Racial Disparity
Teamwork and Safety Conversations to Prevent Wrong Site 2:46 pm – 2:56 pm Amanda Rhee, MD Surgery
2:56 pm – 2:59 pm Q&A Teamwork and Safety Conversations to Prevent Wrong Site Surgery
2:59 pm – 3:09 pm Socioeconomic Implications of Prostate Cancer Therapy Deepak Kapoor, MD
3:09 pm – 3:12 pm Q&A Socioeconomic Implications of Prostate Cancer Therapy
3:12 pm – 6:15 pm JOIN THE MAIN SESSION
MOUNTSINAIUROLOGYCME.ORG | 17 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS SATURDAY, DECEMBER 15 MORNING AGENDA
KIDNEY AND BLADDER CANCER In Collaboration with Society of Urologic Robotic Surgeons and Endourological Society
7:00 am –7:10 am Day Three Welcome Stern Auditorium Ketan Badani, MD
MODERATORS Session I: Upper Tract Disease John Sfakianos, MD and Chandru Sundaram, MD
PANELISTS Jonathan Coleman, MD Daniel Eun, MD Bobby Liaw, MD Peter Wiklund, MD, PhD 7:10 am – 7:25 am Contemporary Management of Upper Tract Urothelial Jonathan Coleman, MD Cancer Endoscopic Management 7:25 am – 7:40 am Mantu Gupta, MD
Ashok Hemal, MD, MCh 7:40 am – 7:50 am Radical Nephroureterectomy with Robotic Assistance: Should it be Standard Care? Complex Case Discussion 7:50 am – 8:00 am Majid Eshghi, MD
8:00 am – 8:15 am Firefly and Upper Tract Reconstruction Daniel Eun, MD
8:15 am – 8:25 am Q&A/Audience Response Question with App
MODERATORS Session II: Kidney I – Partial Nephrectomy Stern Auditorium Jamie Landman, MD Michael Palese, MD
PANELISTS Ralph Clayman, MD, Reza Ghavamian, MD Jim Hu, MD, MPH Dipen Parekh, MD 8:25 am – 8:40 am Optimizing Robotic Partial Nephrectomy Outcome Ketan K. Badani, MD Fluorescence Imaging During Robotic Partial 8:40 am – 8:55 am Ronney Abaza, MD Nephrectomy for Margin Assessment
8:55 am – 9:10 am Complex Partial Nephrectomy Renorrhaphy Daniel Eun, MD Robotic Retroperitoneal Partial Nephrectomy OR 9:10 am – 9:25 am Transitioning from the Davinci Si to Xi for Partial Ronney Abaza, MD Nephrectomy
9:25 am – 9:35 am Q&A
9:35 am – 10:00 am Break/Visit Exhibits
SURGEON 10:00 am – 11:30 am 3-D Live Surgery: Robot Assisted Partial Nephrectomy Ketan Badani, MD
MODERATORS Ash Tewari, MBBS, MCh, Ashok Hemal, MD
PANELISTS Ronney Abaza, MD Daniel Eun, MD Jihad Kaouk, MD Francesco Porpiglia, MD
18 | MOUNTSINAIUROLOGYCME.ORG 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS SATURDAY, DECEMBER 15 AFTERNOON AGENDA
111:30 am – 12:00 pm COMPLEX CASE DISCUSSION MODERATORS Chandru Sundaram, MD
PANELISTS Ronney Abaza, MD Mohamad Allaf, MD Ketan K. Badani, MD Jihad Kaouk, MD Wei-Chun Weng, MD
12:00 pm – 1:00 pm LUNCH
MODERATORS Session III: Kidney Cancer II Stern Auditorium Ketan K. Badani, MD and Michael Stifelman, MD
PANELISTS Reza Ghavamian, MD Jaime Landman, MD Jay Motola, MD Welcome Address 1:00 pm - 1:10 pm Ashok Hemal, MD, MCh President, Society of Urologic Robotic Surgeons Establishing Office-Based Renal Mass Biopsy into Urologic 1:10 pm – 1:25 pm Oncology Practice Jaime Landman, MD Robotic Partial Nephrectomy for Tumors with 1:25 pm – 1:40 pm Jihad Kaouk, MD Sinus Fat Invasion: How to Preserve the Kidney with Negative Margins? Renal Function After Partial Nephrectomy – 1:40 pm – 1:55 pm Dipen Parekh, MD Is Renal Ischemia Important?
1:55 pm – 2:10 pm Selective Clamping: How and Why Michael Stifelman, MD
Pursuit of the Small Renal Mass: Why Is This Specialty 2:10 pm – 2:25pm Ralph Clayman, MD Different From All Other Specialties? Robotic Surgery for Inferior Vena Caval Thrombus 2:25 pm – 2:40 pm Ketan K. Badani, MD
Q&A/Audience Response Question with App 2:40 pm – 2:45 pm
2:45 pm – 3:05 pm PANELISTS In Collaboration with Society of Urologic Robotic Mohamad Allaf, MD Surgeons and Endourological Society Ketan K. Badani, MD SURS SESSION Single Port Robotic Panel Stern Auditorium Daniel Eun, MD Jihad Kaouk, MD Ash Tewari, MBBS, MCh
Audience Response Question with App
3:05 pm – 3:30 pm DEBATE: Is There Still a Role for Cytoreductive Surgery in MODERATORS Advanced Renal Cell Carcinoma? Ketan K. Badani, MD PANELISTS PRO: Mohamad Allaf, MD CON: William Huang, MD
MOUNTSINAIUROLOGYCME.ORG | 19 2018 AGENDA EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS SATURDAY, DECEMBER 15 EVENING AGENDA
3:30 pm – 3:40 pm Audience Response Question with App/BREAK
Session IV: Bladder Cancer I MODERATORS Mutahar Ahmed, MD Michael J. Droller, MD
PANELISTS Michael Cookson, MD Alvin Goh, MD John Sfakianos, MD Rene Javier Sotelo, MD
3:40 pm – 4:05 pm Semi-Live Surgery: Robot-Assisted Radical Cystectomy: Peter Wiklund, MD, PhD
4:05 pm – 4:20 pm New Clinical Trial Designs in Urothelial Carcinoma Bishoy Faltas, MD
4:20 pm – 4:35 pm Zero Narcotic Protocol for Robotic Cystectomy: Surgical John Sfakianos, MD and and Anesthesia Considerations Alan Sim, MD Standardizing Trading with a “Top Down Approach”: 4:35 pm – 4:50 pm Justin Collins, MBChB, MD, FRCS Conclusions from a Train the Trainer Delphi Process
MODERATORS Session V: Bladder Cancer II Stern Auditorium Reza Mehrazin, MD and Bishoy Faltas, MD
PANELISTS Michael J. Droller, MD Erik Goluboff, MD Isuru Jayaratna, MD Biomarkers Associated with Response and Resistance 4:50 pm – 5:05 pm Matthew Galsky, MD to Immune Checkpoint Blockade in Urothelial Cancer Do All Patients with Muscle Invasive Bladder Cancer 5:05 pm – 5:15 pm Require Neoadjuvant Chemotherapy? Hugh Lavery, MD A Review of Evidence
5:15 pm – 5:30 pm Bladder Cancer Patients Treated with Ipilimumab: Sacha Gnjatic, PhD Identifying Neoantigen-Specific T-Cell Responses
5:30 pm – 5:45 pm Genomic Profile Upper and Lower Tract John Sfakianos, MD
Bladder Cancer Health Services: 5:45 pm – 5:55 pm Nikhil Waingankar, MD Implications of the Volume-Outcome Effect
5:55 pm – 6:05 pm Q&A Use of ICG as a Predictive Tool for 6:05 pm – 6:20 pm Ketan K. Badani, MD Ureteral-Enteric Strictures Intracorporeal vs. Extracorporeal Urinary Diversion 6:20 pm – 6:30 pm Reza Mehrazin, MD After Robotic Cystectomy Intracorporeal Urinary Diversion for 6:30 pm – 6:45 pm Alvin Goh, MD Robotic Radical Cystectomy
6:45 pm – 6:59 pm End of Symposium Conclusion Ash Tewari, MBBS, MCh
20 | MOUNTSINAIUROLOGYCME.ORG